- Feb 5, 2002
- 184,156
- 67,247
- Country
- United States
- Gender
- Female
- Faith
- Catholic
- Marital Status
- Married
- Politics
- US-Others
Nearly every Republican senator signed a letter Thursday urging the Food and Drug Administration (FDA) to reverse its decision to approve a “generic” version of the abortion pill mifepristone, which may come onto the market by January if no action is taken.
Sen. Lindsey Graham, joined by 50 of his colleagues, wrote that “we are deeply concerned” with the FDA’s decision. The FDA approved the generic mifepristonein late September without a public announcement.
In the letter, the senators wrote that the approval “appears inconsistent” with recent comments from Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who confirmed in early September that HHS is reviewing the safety of the abortion pill and said President Joe Biden’s administration “twisted the data” to downplay health concerns about the drug.
“Out of respect for this important review, and with full confidence in your dedication to protecting women’s health, states’ rights, and unborn life, we urge you to take decisive action to reevaluate whether this generic version of mifepristone is suitable to enter the market,” the senators wrote.
Continued below.
Sen. Lindsey Graham, joined by 50 of his colleagues, wrote that “we are deeply concerned” with the FDA’s decision. The FDA approved the generic mifepristonein late September without a public announcement.
In the letter, the senators wrote that the approval “appears inconsistent” with recent comments from Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who confirmed in early September that HHS is reviewing the safety of the abortion pill and said President Joe Biden’s administration “twisted the data” to downplay health concerns about the drug.
“Out of respect for this important review, and with full confidence in your dedication to protecting women’s health, states’ rights, and unborn life, we urge you to take decisive action to reevaluate whether this generic version of mifepristone is suitable to enter the market,” the senators wrote.
Continued below.
51 senators ask FDA to rescind approval of new ‘generic’ abortion pill
Sen. Lindsey Graham, joined by 50 of his colleagues, wrote that “we are deeply concerned” with the FDA’s decision to approve the generic mifepristone.